The relationship between serum ferritin concentration and the amount of storage iron has been studied in normal subjects. A high degree of correlation was demonstrated between serum ferritin concentration and storage iron measured by quantitative phlebotomy. The possible advantages of assessing iron stores by using the serum ferritin concentration are discussed.
Ferritin is the main iron storage compound in the body and is present mainly in the reticuloendothelial cells of the liver, spleen, and bone marrow. A small amount is normally found in the circulating plasma, the concentration varying between 10 and 200,ug per litre (Jacobs, Miller, Worwood, Beamish, and Wardrop, 1972) . The mean concentration in men is twice that in women suggesting that the serum level reflects total body stores. This is supported by the observation that patients with irondeficiency anaemia have concentrations below 10 ,.ug per litre and patients with iron overload have greatly increased levels . Although there is a good correlation between serum ferritin concentration and iron load in pathological states there is no evidence that this correlation exists in normal subjects.
The most accurate method for measuring iron stores is by quantitative phlebotomy (Haskins, Stevens, Finch, and Finch, 1952; Weinfeld, 1970 Five of the males were blood donors but none had given blood in the three months before the study and their iron status was considered to be in equilibrium. Their haematological characteristics did not differ significantly from those of other men.
METHODS
Serial phlebotomies of approximately 400 ml were performed at weekly intervals in the majority of the subjects. Some were bled more frequently but intervals greater than eight days were exceptional.
Phlebotomy was continued until the following criteria were satisfied: (1) The haemoglobin concentration fell below 11 g per 100 ml andwas maintained at this level without further phlebotomy for a period of 14 days. (2) The transferrin saturation was consistently below 15 %, indicating depletion of iron stores (Bainton and Finch, 1964) .
After each phlebotomy the volume of blood removed was measured and its haemoglobin concentration determined. Serum iron, total ironbinding capacity, and ferritin concentrations were also determined.
Haematological parameters were measured using the Coulter S automatic cell counter. Serum iron concentration and total iron-binding capacity were Haemoglobin (g/100 ml) Serum ferritin concentration and iron stores in normal subjects measured by a modification of the method of Young and Hicks (1965) . Serum ferritin concentration was measured by using the immunoradiometric assay of Addison, Beamish, Hales, Hodgkins, Jacobs, and Llewellin (1972) . The amount of storage iron was calculated by the method of Haskins, Stevens, Finch, and Finch (1952) . The total amount of iron removed by phlebotomy was calculated from the quantity of haemoglobin removed. Iron lost in reducing the subjects' haemoglobin concentration from its initial to its final value was calculated using an estimated blood volume (Nadler, Hidalgo, and Bloch, 1962) . The difference between these values represents the total amount of mobilizable storage iron. A correction for the amount of iron absorbed during the study, estimated as 3 mg daily, was also made (Haskins et al, 1952; Olsson, 1972 There was a close correlation between the serum ferritin concentration and mobilizable iron stores (fig 1, r = 0-83, p < 0 001). The relation between these two parameters is expressed by the equation y = 11*8 + 0 13x, where y is the ferritin concentration in ,tg/litre and x is the storage iron in milligrams. The correlation when iron stores are uncorrected for absorbed iron was similar (r = 0-80, p < 0*001). The correlation between the calculated total circulating ferritin and iron stores was also very similar (r = 0-843, p < 0-001).
Ferritin concentration fell as phlebotomy was repeated. In all cases the fall in ferritin concentration preceded or coincided with a fall in transferrin saturation, the former was the more usual pattern whilst the latter tended to occur in those subjects with the least iron stores.
Discussion
The results obtained for iron stores in both males and females are in close agreement with published values using quantitative phlebotomy and they show the same wide variation. Published values (means in mg) with the authors and numbers of subjects in brackets are as shown in table II. Quantitative phlebotomy is the standard reference method for assessing iron stores and measures the amount of mobilizable iron available for haemoglobin synthesis. In practice it is a lengthy and inconvenient procedure for which indirect, though more convenient methods, are usually substituted. Some, like the visual assessment of iron in marrow or liver biopsies, cannot be quantitated. The quantitative methods include the estimation of desferrioxamine-induced urinary excretion (Olsson, 1972; Balcerzak, Westerman, Heinle, and Taylor, 1968) and non-haem iron concentration in liver (Weinfeld, 1970 Olsson (1972) 750 (11) 110 (14) Balcerzak et al (1968) 687 (11) Pritchard and Mason (1964) 819 (3) 254 (10) Haskins et al (1952) 844 (2) 93 (2) Hynes (1949) 600 (1) Present data 900 (7) 210 (10) 400 ( (Olsson, 1972; Balcerzak et al, 1968; Karabus and Fielding, 1967) . The desferrioxamine test involves one or two intramuscular injections followed by a 6 to 24-hour urine collection and a biopsy is necessary to determine the non-haem iron content of liver. These procedures have to be compared to the single sample of venous blood required for measurement of ferritin concentration.
Direct measurement of a segment of the body ferritin pool appears to give a valid indication of total body iron stores both in normal subjects and in those with iron deficiency and iron ovetload. The present data suggest that 1 ,ug ferritin per litre of serum represents about 8 mg of storage iron. In a series of 75 healthy males and 44 healthy females the mean serum ferritin concentration was 69 and 35 ,ug per litre respectively corresponding to mean iron stores of 552 mg in the men and 280 mg in the women.
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